Andrews William T. sold CPRX
June 3, 2025 · Form 4 insider transaction
Andrews William T. sold 3,052 shares of Catalyst Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 367 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,052
Price
$0.00
Total value
N/A
InsiderAndrews William T.
Role—
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateJune 3, 2025
Filing dateJune 5, 2026
Shares owned after240,195
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.; Derivative securities vest in equal tranches, 1/5th each on June 2, 2026, 2027, 2028, 2029, and 2030.; Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on June 3, 2026.